Skip to main content

Fresh & Ready Foods Recalls Products After Listeria Outbreak

Medically reviewed by Carmen Pope, BPharm. Last updated on May 13, 2025.

By I. Edwards HealthDay Reporter

TUESDAY, May 13, 2025 — At least 10 people in the U.S. were hospitalized with listeria infections linked to ready-to-eat foods, federal officials said.

The U.S. Food and Drug Administration (FDA) and other agencies traced the outbreak to foods produced by Fresh & Ready Foods LLC of San Fernando, California. The people who got sick were in California and Nevada, according to a report from CNN.

The recalled products were sold in Arizona, California, Nevada and Washington. The items were sold at hospitals, hotels, convenience stores, airports, airlines and other places.

Listeria symptoms typically develop within two weeks of eating tainted food. Common symptoms include fever, muscle aches, nausea, vomiting and diarrhea. In serious cases, people can experience headaches, stiff neck, confusion, loss of balance or seizures.

The FDA said the outbreak investigation began last year but was reopened in April after listeria was found in food samples from Fresh & Ready Foods. The bacteria matched the strain linked to the sick patients, CNN reported.

In a news release, Fresh & Ready Foods said the company acted quickly, including removing equipment, to fix the problem. The FDA also found that six of the 10 patients had been hospitalized before developing listeria.

Products from Fresh & Ready Foods were served at least three of those health care facilities.

The U.S. Centers for Disease Control and Prevention (CDC) said samples from sick patients were collected between December 2023 and September 2024.

Fresh & Ready Foods has voluntarily recalled products with "use by" dates from April 22 to May 19, 2025, CNN said.

The items were sold under the brand names Fresh & Ready Foods, City Point Market Fresh Food to Go and Fresh Take Crave Away.

Sources

  • CNN, May 12, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted May 2025

Read this next

FDA Authorizes First AI Platform for Breast Cancer Prediction

FRIDAY, June 6, 2025 -- The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a...

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

FRIDAY, June 6, 2025 — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in...

Long-Lasting HIV Prevention Shot Headed Toward Approval

FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.